• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物信息学分析的肥厚型心肌病潜在诊断生物标志物和生物学途径的鉴定。

Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.

机构信息

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.

出版信息

Genes (Basel). 2022 Mar 17;13(3):530. doi: 10.3390/genes13030530.

DOI:10.3390/genes13030530
PMID:35328083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8951232/
Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic heterogeneous disorder and the main cause of sudden cardiac death in adolescents and young adults. This study was aimed at identifying potential diagnostic biomarkers and biological pathways to help to diagnose and treat HCM through bioinformatics analysis. We selected the GSE36961 dataset from the Gene Expression Omnibus (GEO) database and identified 893 differentially expressed genes (DEGs). Subsequently, 12 modules were generated through weighted gene coexpression network analysis (WGCNA), and the turquoise module showed the highest negative correlation with HCM (cor = −0.9, p-value = 4 × 10−52). With the filtering standard gene significance (GS) < −0.7 and module membership (MM) > 0.9, 19 genes were then selected to establish the least absolute shrinkage and selection operator (LASSO) model, and LYVE1, MAFB, and MT1M were finally identified as key genes. The expression levels of these genes were additionally verified in the GSE130036 dataset. Gene Set Enrichment Analysis (GSEA) showed oxidative phosphorylation, tumor necrosis factor alpha-nuclear factor-κB (TNFα-NFκB), interferon-gamma (IFNγ) response, and inflammatory response were four pathways possibly related to HCM. In conclusion, LYVE1, MAFB, and MT1M were potential biomarkers of HCM, and oxidative stress, immune response as well as inflammatory response were likely to be associated with the pathogenesis of HCM.

摘要

肥厚型心肌病(HCM)是一种遗传异质性疾病,也是青少年和年轻成年人心源性猝死的主要原因。本研究旨在通过生物信息学分析,确定潜在的诊断生物标志物和生物学途径,以帮助诊断和治疗 HCM。我们从基因表达综合数据库(GEO)中选择了 GSE36961 数据集,并鉴定了 893 个差异表达基因(DEGs)。随后,通过加权基因共表达网络分析(WGCNA)生成了 12 个模块,其中绿松石模块与 HCM 的相关性最高(cor=-0.9,p 值=4×10−52)。根据基因显著性(GS)<−0.7 和模块成员性(MM)>0.9 的过滤标准,筛选出 19 个基因,建立最小绝对收缩和选择算子(LASSO)模型,最终确定 LYVE1、MAFB 和 MT1M 为关键基因。这些基因的表达水平在 GSE130036 数据集上进一步验证。基因集富集分析(GSEA)显示,氧化磷酸化、肿瘤坏死因子α-核因子κB(TNFα-NFκB)、干扰素-γ(IFNγ)反应和炎症反应可能与 HCM 相关。总之,LYVE1、MAFB 和 MT1M 可能是 HCM 的潜在生物标志物,氧化应激、免疫反应和炎症反应可能与 HCM 的发病机制有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/d369e7ae5b3f/genes-13-00530-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/87e5923e9ee7/genes-13-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/9e8a25d1591d/genes-13-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/3c2849a40785/genes-13-00530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/f00c6ff75926/genes-13-00530-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/7df28c1fb5be/genes-13-00530-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/ddc067642fff/genes-13-00530-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/8a72afbc6ab3/genes-13-00530-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/d369e7ae5b3f/genes-13-00530-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/87e5923e9ee7/genes-13-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/9e8a25d1591d/genes-13-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/3c2849a40785/genes-13-00530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/f00c6ff75926/genes-13-00530-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/7df28c1fb5be/genes-13-00530-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/ddc067642fff/genes-13-00530-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/8a72afbc6ab3/genes-13-00530-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ac/8951232/d369e7ae5b3f/genes-13-00530-g008.jpg

相似文献

1
Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.基于生物信息学分析的肥厚型心肌病潜在诊断生物标志物和生物学途径的鉴定。
Genes (Basel). 2022 Mar 17;13(3):530. doi: 10.3390/genes13030530.
2
Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.加权基因共表达网络分析揭示了与肥厚型心肌病诊断相关的关键生物标志物。
Hereditas. 2020 Oct 24;157(1):42. doi: 10.1186/s41065-020-00155-9.
3
Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.通过 bulk 和单细胞 RNA 测序数据的综合分析鉴定肥厚型心肌病的免疫状态。
Comput Math Methods Med. 2022 Oct 4;2022:7153491. doi: 10.1155/2022/7153491. eCollection 2022.
4
Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.肥厚型心肌病患者中与免疫细胞浸润特征相关的有前景的诊断生物标志物的识别与验证。
Life Sci. 2021 Nov 15;285:119956. doi: 10.1016/j.lfs.2021.119956. Epub 2021 Sep 11.
5
Exploring Hypertrophic Cardiomyopathy Biomarkers through Integrated Bioinformatics Analysis: Uncovering Novel Diagnostic Candidates.通过综合生物信息学分析探索肥厚型心肌病生物标志物:发现新型诊断候选物
Cardiol Res Pract. 2024 Jul 4;2024:4639334. doi: 10.1155/2024/4639334. eCollection 2024.
6
Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis.鉴定和验证细胞焦亡相关基因作为肥厚型心肌病的潜在生物标志物:一项全面的生物信息学分析
Medicine (Baltimore). 2024 Jan 26;103(4):e36799. doi: 10.1097/MD.0000000000036799.
7
Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.基于集成机器学习的肥厚型心肌病诊断基因生物标志物预测。
J Int Med Res. 2023 Nov;51(11):3000605231213781. doi: 10.1177/03000605231213781.
8
Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.生物信息学与免疫浸润分析揭示肥厚型心肌病发病机制中的关键途径及免疫细胞
Front Cardiovasc Med. 2021 Aug 23;8:696321. doi: 10.3389/fcvm.2021.696321. eCollection 2021.
9
Weighted gene coexpression network analysis reveals negative regulation of hypertrophic cardiomyopathy by carboxylesterase 1 and cathepsin C.加权基因共表达网络分析揭示羧基酯酶 1 和组织蛋白酶 C 对肥厚型心肌病的负向调控作用。
Gen Physiol Biophys. 2023 Jul;42(4):361-372. doi: 10.4149/gpb_2023009.
10
Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.基于共表达分析鉴定与肥厚型心肌病相关的生物标志物。
J Cell Physiol. 2019 Dec;234(12):21999-22008. doi: 10.1002/jcp.28762. Epub 2019 May 6.

引用本文的文献

1
Investigating the role of long non-coding RNA in hypertrophic cardiomyopathy.研究长链非编码RNA在肥厚型心肌病中的作用。
bioRxiv. 2025 Jul 31:2025.07.26.666851. doi: 10.1101/2025.07.26.666851.
2
Uncovering dendritic cell specific biomarkers for diagnosis and prognosis of cardiomyopathy using single cell RNA sequencing and comprehensive bioinformatics analysis.使用单细胞RNA测序和综合生物信息学分析揭示用于心肌病诊断和预后的树突状细胞特异性生物标志物。
Sci Rep. 2025 May 26;15(1):18424. doi: 10.1038/s41598-024-78011-3.
3
Identification of Diagnostic Biomarkers for Colorectal Polyps Based on Noninvasive Urinary Metabolite Screening and Construction of a Nomogram.

本文引用的文献

1
Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.通过加权基因共表达网络分析(WGCNA)和竞争性内源RNA(ceRNA)网络分析鉴定肥厚型心肌病的易感性模块和基因
Front Cell Dev Biol. 2022 Feb 1;9:822465. doi: 10.3389/fcell.2021.822465. eCollection 2021.
2
Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy.肥厚型心肌病的功能障碍网络和突变基因。
J Healthc Eng. 2022 Jan 28;2022:8680178. doi: 10.1155/2022/8680178. eCollection 2022.
3
Bioinformatic Analysis Identified Hub Genes Associated with Heterocyclic Amines Induced Cytotoxicity of Peripheral Blood Mononuclear Cells.
基于非侵入性尿液代谢物筛查的结直肠息肉诊断生物标志物鉴定及列线图构建
Cancer Med. 2025 Apr;14(7):e70762. doi: 10.1002/cam4.70762.
4
The Relationship Between BigET-1 and Cardiac Remodeling in Patients with Hypertrophic Obstructive Cardiomyopathy.肥厚性梗阻性心肌病患者中BigET-1与心脏重塑的关系
Mol Biotechnol. 2024 Nov 19. doi: 10.1007/s12033-024-01308-1.
5
Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.系统性炎症与梗阻性肥厚型心肌病患者的心肌纤维化相关。
ESC Heart Fail. 2025 Feb;12(1):582-591. doi: 10.1002/ehf2.15109. Epub 2024 Oct 17.
6
Identification of crosstalk genes and immune characteristics between Alzheimer's disease and atherosclerosis.鉴定阿尔茨海默病与动脉粥样硬化之间的串扰基因和免疫特征。
Front Immunol. 2024 Aug 12;15:1443464. doi: 10.3389/fimmu.2024.1443464. eCollection 2024.
7
Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers.机器学习在肥厚型心肌病和癌症新型生物标志物中的应用及实验验证。
J Cell Mol Med. 2024 Aug;28(16):e70034. doi: 10.1111/jcmm.70034.
8
Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.基于加权基因共表达网络分析(WGCNA)和套索(LASSO)分析鉴定糖尿病性心肌病中的重要模块和生物标志物。
Front Endocrinol (Lausanne). 2024 Feb 8;15:1185062. doi: 10.3389/fendo.2024.1185062. eCollection 2024.
9
Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.基于集成机器学习的肥厚型心肌病诊断基因生物标志物预测。
J Int Med Res. 2023 Nov;51(11):3000605231213781. doi: 10.1177/03000605231213781.
10
Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy.心肌细胞排列紊乱的局灶区和正常区的空间转录组分析在人类肥厚型心肌病中的应用。
Int J Mol Sci. 2023 Aug 10;24(16):12625. doi: 10.3390/ijms241612625.
生物信息学分析鉴定与杂环胺诱导外周血单个核细胞细胞毒性相关的枢纽基因。
Genes (Basel). 2021 Nov 25;12(12):1888. doi: 10.3390/genes12121888.
4
Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses.基于生物信息学分析的肥厚型心肌病患者特征性免疫相关基因的鉴定与验证
Front Cardiovasc Med. 2021 Oct 26;8:752559. doi: 10.3389/fcvm.2021.752559. eCollection 2021.
5
WGCNA Identifies Translational and Proteasome-Ubiquitin Dysfunction in Rett Syndrome.WGCNA 鉴定雷特综合征中的翻译和蛋白酶体-泛素功能障碍。
Int J Mol Sci. 2021 Sep 15;22(18):9954. doi: 10.3390/ijms22189954.
6
Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.肥厚型心肌病患者中与免疫细胞浸润特征相关的有前景的诊断生物标志物的识别与验证。
Life Sci. 2021 Nov 15;285:119956. doi: 10.1016/j.lfs.2021.119956. Epub 2021 Sep 11.
7
Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.生物信息学与免疫浸润分析揭示肥厚型心肌病发病机制中的关键途径及免疫细胞
Front Cardiovasc Med. 2021 Aug 23;8:696321. doi: 10.3389/fcvm.2021.696321. eCollection 2021.
8
Multi-factor regulatory network and different clusters in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病的多因素调控网络和不同聚类。
BMC Med Genomics. 2021 Aug 6;14(1):199. doi: 10.1186/s12920-021-01036-4.
9
Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.小鼠和人类肥厚型心肌病中分子表型的差异。
Sci Rep. 2021 Jun 23;11(1):13163. doi: 10.1038/s41598-021-89451-6.
10
Mycobacterium tuberculosis EsxL induces TNF-α secretion through activation of TLR2 dependent MAPK and NF-κB pathways.结核分枝杆菌 EsxL 通过激活 TLR2 依赖性 MAPK 和 NF-κB 通路诱导 TNF-α 分泌。
Mol Immunol. 2021 Feb;130:133-141. doi: 10.1016/j.molimm.2020.11.020. Epub 2021 Jan 6.